BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16889964)

  • 1. Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring.
    Messaoudi S; Anizon F; Peixoto P; David-Cordonnier MH; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2006 Nov; 14(22):7551-62. PubMed ID: 16889964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of isogranulatimide analogues.
    Hugon B; Anizon F; Bailly C; Golsteyn RM; Pierré A; Léonce S; Hickman J; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2007 Sep; 15(17):5965-80. PubMed ID: 17582773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxicities of 7-aza rebeccamycin analogues bearing various substituents on the sugar moiety, on the imide nitrogen and on the carbazole framework.
    Messaoudi S; Anizon F; Léonce S; Pierré A; Pfeiffer B; Prudhomme M
    Eur J Med Chem; 2005 Oct; 40(10):961-71. PubMed ID: 15907347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
    Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
    Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.
    Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Joubert A; Bailly C; Renard P; Hickman J; Prudhomme M
    J Med Chem; 2003 Feb; 46(4):609-22. PubMed ID: 12570382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles.
    Conchon E; Anizon F; Aboab B; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2008 Apr; 16(8):4419-30. PubMed ID: 18321713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and biological activities of rebeccamycin analogues with uncommon sugars.
    Zhang G; Shen J; Cheng H; Zhu L; Fang L; Luo S; Muller MT; Lee GE; Wei L; Du Y; Sun D; Wang PG
    J Med Chem; 2005 Apr; 48(7):2600-11. PubMed ID: 15801850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
    Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
    J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebeccamycin analogues as anti-cancer agents.
    Prudhomme M
    Eur J Med Chem; 2003 Feb; 38(2):123-40. PubMed ID: 12620658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.
    Conchon E; Anizon F; Aboab B; Prudhomme M
    J Med Chem; 2007 Sep; 50(19):4669-80. PubMed ID: 17722905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives.
    Moreau P; Gaillard N; Marminon C; Anizon F; Dias N; Baldeyrou B; Bailly C; Pierré A; Hickman J; Pfeiffer B; Renard P; Prudhomme M
    Bioorg Med Chem; 2003 Nov; 11(23):4871-9. PubMed ID: 14604648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebeccamycin derivatives as dual DNA-damaging agents and potent checkpoint kinase 1 inhibitors.
    Marminon C; Anizon F; Moreau P; Pfeiffer B; Pierré A; Golsteyn RM; Peixoto P; Hildebrand MP; David-Cordonnier MH; Lozach O; Meijer L; Prudhomme M
    Mol Pharmacol; 2008 Dec; 74(6):1620-9. PubMed ID: 18768386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety.
    Anizon F; Moreau P; Sancelme M; Laine W; Bailly C; Prudhomme M
    Bioorg Med Chem; 2003 Aug; 11(17):3709-22. PubMed ID: 12901916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Sevère D; Riou JF; Goossens JF; Hénichart JP; Bailly C; Labourier E; Tazzi J; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1999 May; 42(10):1816-22. PubMed ID: 10346933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bis-imide granulatimide analogues as potent Checkpoint 1 kinase inhibitors.
    Hénon H; Messaoudi S; Anizon F; Aboab B; Kucharczyk N; Léonce S; Golsteyn RM; Pfeiffer B; Prudhomme M
    Eur J Pharmacol; 2007 Jan; 554(2-3):106-12. PubMed ID: 17134696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and antiproliferative activities of new rebeccamycin derivatives with the sugar unit linked to both indole nitrogens.
    Marminon C; Anizon F; Moreau P; Léonce S; Pierré A; Pfeiffer B; Renard P; Prudhomme M
    J Med Chem; 2002 Mar; 45(6):1330-9. PubMed ID: 11882002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogues of antifungal tjipanazoles from rebeccamycin.
    Voldoire A; Moreau P; Sancelme M; Matulova M; Léonce S; Pierré A; Hickman J; Pfeiffer B; Renard P; Dias N; Bailly C; Prudhomme M
    Bioorg Med Chem; 2004 Apr; 12(8):1955-62. PubMed ID: 15051063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolocarbazole glycosides in inactive conformations.
    Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
    Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
    Cho HJ; Jung MJ; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-step synthesis from rebeccamycin of an efficient checkpoint kinase 1 inhibitor.
    Anizon F; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Eur J Med Chem; 2009 May; 44(5):2234-8. PubMed ID: 18602198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.